Greg Blaney, MD, graduated from the University of Ottawa in 1974. Following internship at Edmonton General he joined a Community Health clinic in Ottawa. From 1987 to 1990 he was a teaching assistant in the College of Osteopathy of the CME program at Michigan State University, having trained in both conventional and manual medicine during the first two decades of his career. He went on to also gain competence in Acupuncture and Homotoxicology, was a medical advisor to the LaLeche league, the Childbirth Education Association, the RCMP and the Bank of Canada. He lectured in the University of Ottawa’s Residency program, and its Masters program in nutrition. Dr. Blaney is currently using Autoimmunity Research Foundation’s Marshall Protocol to save the lives of hundreds of patients with a wide variety of chronic inflammatory diseases.
How did you become aware of the Marshall Protocol (MP)?
Before learning about the Marshall Protocol my work had evolved into a chronic pain practice, where I focused on osteopathy and trigger point injections. Despite the fact that some people seemed to benefit somewhat from these therapies, I always had a certain group of patients with chronic symptoms that simply did not respond to anything I tried. I had one patient who was actually aggravated by most of these therapies and displayed multiple symptoms in different areas of her body that did not respond to treatment. At the same time, I was also treating a woman who had been diagnosed with Lyme disease ten years before becoming my patient, however her symptoms had gone into temporary remission. Although she had been told by another doctor that she was “cured”, when she was in a car accident, all of her Lyme symptoms returned. After being tested, she was once again positive for Lyme.
She’s a Senior Principal Research Scientist and the Research Program Leader of Enzymology & Synthetic Biology for the Division of Entomology, Commonwealth Scientific and Industrial Research Organization, in Canberra, Australia. Despite her broad background in the biological sciences, and her PhD in immunology, she was unaware of the pathogens causing her son’s illness– that is until she learned about Autoimmunity Research Foundation’s Marshall Protocol. Dr. Robyn Russell will now take your questions….
When did Matt start to get sick? What happened?
Everything started in June 2004 when Matt was 12 years old. Matt started to have very painful headaches. It was in June that my husband and I first wrote one of Matt’s teachers a note saying that he wasn’t able to complete his homework because of his headache. We were concerned because a child his age should certainly not be suffering from debilitating headaches. We saw a doctor and he told us that Matt had a sinus infection. Over the next few months he was put on courses of high-dose antibiotics but the head symptoms would always return. Finally the doctor said, “I have no idea why Matt is not getting better.”
We were referred to an ear, nose and throat doctor but there was a three-month waiting list in order to see him. During the time we had to wait for the appointment Matt began to develop urinary tract infections as well, which is uncommon for a boy. We had a family vacation planned to Europe that was centered around a scientific conference that my husband and I were planning to attend. While on the trip, Matt continually woke up with a terrible headache. As the day wore on, we’d do everything in our power to distract him, saying “Look, the Louvre! The Mona Lisa!”, but Matt just wanted to go home and rest, and the distraction was a losing battle. During the trip Matt did find that swimming helped his headache.
By 2003 she had physically hit rock bottom and was completely unable to maintain her farm. Now, thanks to Autoimmunity Research Foundation’s Marshall Protocol, she has the energy she had in college. Sue Andorn will now take your questions.
1. How long have you been on the Marshall Protocol (MP)?
I started my 4th year on the Marshall Protocol in June 2007.
2. Tell me about your symptoms before you started the Marshall Protocol? How did you get sick?
When I was a child I was quite healthy. I walked four miles to get to school and had perfect attendance. My first sign of illness occurred in college when I got a polynidal cyst on my tailbone. It burst internally before it could be removed. I now know that it was probably filled with bacteria that subsequently drained throughout my body. I graduated from college with a degree in microbiology and proceeded to work at Sterling Drug Company, where our team began doing research on a measles vaccine. Because we were working with germs, I had to get an Asian Flu vaccine. Within minutes of receiving the injection I went into anaphalactic shock. Six months later I got extremely ill with the flu despite the vaccine. Knowing what I know now, it was a vaccine contaminated with L-form bacteria. I never really recovered. That was the start of a downhill slide that lasted 50 years.
Dr. Alan Cantwell has investigated the phenomenon of cancer bacteria for over thirty years. A graduate of New York Medical College, Cantwell completed a residency program in dermatology at Long Beach Veteran’s Administration Hospital in Long Beach, CA and then practiced in the dermatology department of Kaiser-Permanente in Hollywood, California, from 1965 until his retirement in 1994. Dr. Cantwell is the author of more than thirty published papers on breast cancer, lymphoma, Kaposi’s sarcoma, Hodgkin’s Disease, lupus, scleroderma, AIDS, and other immunological diseases. These papers have appeared in many peer-reviewed journals, including Growth, International Journal of Dermatology, Journal of Dermatologic Surgery and Oncology, and the Archives of Dermatology. He has also written The Cancer Microbe and Four Women Against Cancer and several books on AIDS.
1. How did you become interested in looking for bacteria, first in diseases like scleroderma and later in cancer?
It all started when I was a second year resident in dermatology. I was in the medical library and I came across a paper in the Southern Medical Journal describing a group of people who had been given allergy injections and who subsequently developed deep skin infection with tuberculosis-like germs. It was thought the allergy injection bottles were contaminated with these bacteria.
“Bacterial L-forms are among the most unusual creatures in nature. Once one has seen their strange habits and life style, one starts to work on L-forms with great enthusiasm because their existence in vivo and in vitro gives rise to more questions in classical microbiology, immunology and infectious diseases.
Researching L-forms is like trying to catch a fish that appears on the surface and quickly dives back into the sea. It is almost impossible to catch it with bare hands. There are better chances of catching the fish by hook and line but chance is always powerful when efforts are joined and fishing nets are put into use.”
And just who is able to describe the process of culturing L-form bacteria so eloquently? She’s an Associate Professor at the Department of Pathogenic Bacteria Institute of Microbiology at the Bulgarian Academy of Sciences, who’s worked with L-form bacteria for the last 15 years. Meet Nadya Markova.
1. What led you to become interested in L-form bacteria?
I graduated as a medical doctor, but my interest in microbiology led me to the Bulgarian Academy of Sciences (where I defended my PhD thesis in the field of medical microbiology). Researchers already working there at the time had great experience in L-form research and had made many interesting observations about the bacteria, all of which sparked my interest. They were my teachers, who inspired me to continue their research in the same field.
2. How long have you been working with L-form bacteria? How many people do you currently work with and how to they contribute to the research environment?
I started thinking about how L-form bacteria change form in the beginning of the 90s, and my interest in them has risen ever since. Unfortunately, our research team is comprised of only 5 people. One of them must be mentioned, my teacher Professor Lilia Michailova. She is an excellent electron microscopist and, without her, our achievements wouldn’t have been possible. I’m really glad that she is still active and that we continue to work together.
Two years ago he was bedridden with severe body and joint pain. Now he’s back at work and feels better than he has in years. Join Ival Meyer as he talks about his experience thus far on Autoimmunity Research Foundation’s Marshall Protocol.
1. What were your symptoms like before starting the Marshall Protocol (MP)?
As I got sick, the first symptoms I felt were confusion, fatigue, and a terrible flu-like feeling. After a while I thought that maybe I’d had a stroke. Of course my doctor told me to take Prozac. Well, I knew I wasn’t crazy and sure enough after about another year my joints started to hurt as well. That is when my doctor diagnosed me with rheumatoid arthritis. Next thing I knew, my rheumatoid arthritis pain started to get very bad. I had a great deal of pain in my hands and feet. The ligaments were so stiff that my toes started to turn and bend out of shape. My hands were getting very close to doing the same thing right when I found the MP. I’ve also had severe upper and lower back pain my whole life. When I was in high school I had to quit sports because of the back pain.
All images of bacteria in this post are taken, with author’s permission from Clinical Microbiological Reviews, published in 1997, 10(2), 320-344.
Gerald Domingue is a medical researcher and academic who served as Professor of Urology, Microbiology and Immunology in the Tulane University School of Medicine and Graduate School for thirty years and also as Director of Research in Urology. He is currently retired and resides in Zurich, Switzerland where he is engaged in painting and creative writing. At retirement he was honored with the title of Professor Emeritus at Tulane. Prior to Tulane, he served on the faculty of St. Louis University, was a lecturer at Washington University and director of clinical microbiology in St. Louis City Hospital, St. Louis, MO.
A History of Cell Wall Deficient Bacteria: A Selection of Researchers Who Have Worked with the L-form
Author: Amy Proal18 Aug 2007
A wide body of research has shown that classical forms of bacteria often transform into tiny variants of the same species, losing their cell walls in the process. They are then referred to as L-form or cell wall deficient (CWD) bacteria. Although researchers have known about L-form bacteria for over a century, up until recently they have not fully understood their connection to chronic disease. It is now known that these bacteria are responsible for causing a wide array of chronic diseases including rheumatoid arthritis, Chronic Fatigue Syndrome, Lyme disease, and sarcoidosis.
Over the past century researchers have identified over 50 different species of bacteria capable of transforming into the L-form and it is likely that even more species will be discovered in the coming years. The vast majority of researchers and doctors are not aware that L-form bacteria are present in their patients because the pathogens will not grow under standard laboratory conditions and must be cultured in a different medium and at a different temperature than classical bacteria.
In 2005, a team of researchers at the Royal Brompton Hospital in London published a paper that reviewed the clinical significance of the L-form as an infectious agent. The review discussed the work of hundreds of researchers who have cultivated the L-form and implicated it in a wide array of diseases.
Interview with Guss Wilkinson – Sarcoidosis, psoriasis, insomnia
Author: Amy Proal10 Aug 2007
He’s a 43 year-old from Hamilton, New Zealand. First diagnosed with the lung disease sarcoidosis in 2002, he started Autoimmunity Research Foundation’s Marshall Protocol in October 2003. Guss Wilkinson will now take your questions.
1. What kind of condition were you in before starting the Marshall Protocol?
I was pretty miserable. I couldn’t take more than five steps at a time before stopping to gasp for breath. Then I had a slew of other symptoms. I was just 8-years old when I started to be plagued by psoriasis (a skin disease) and mild arthritis. Then, in the eighties I developed kidney stones and started to have frequent night sweats. I began to have terrible problems with insomnia. Around 2000 I began to experience short-term memory loss and concentration problems.
2. How did those memory and concentration problems affect your ability to work?
It was embarrassing. My boss came up to me one day and said, “Have you finished your report”? I thought to myself, “What report”!? I had absolutely no memory of my boss having asked me to write the report. But then, what was even more offsetting was that when I checked my files I realized that I had written the report, I just had no memory of writing it. I also had big problems remembering names and often confused simple terminology when I was writing.
Read more
NEWS FLASH
Peer-Reviewed Papers
Amy's Conference Presentations
Featured Articles
Patient Interviews
About Amy Proal
Amy Proal graduated from Georgetown University in 2005 with a degree in biology. While at Georgetown, she wrote her senior thesis on Chronic Fatigue Syndrome and the Marshall Protocol.
Amy has spoken at several international conferences and authored several peer-reviewed papers on the intersection of bacteria and chronic disease.
If you have questions about the MP, please visit CureMyTh1.org where volunteer patient advocates will answer your questions. Another good resource is the MP Knowledge Base, which is scheduled to be completed within the next year.
